Elevate levels of plasma osteoprotegerin are association with all-cause mortality risk and atherosclerosis in patients with stages 3 ~ 5 chroneic kidney disease.
Elevated levels of plasma osteoprotegerin are associated with all-cause mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney disease.